Javier Garzón

5.2k total citations
147 papers, 4.4k citations indexed

About

Javier Garzón is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Javier Garzón has authored 147 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Cellular and Molecular Neuroscience, 116 papers in Molecular Biology and 51 papers in Physiology. Recurrent topics in Javier Garzón's work include Neuropeptides and Animal Physiology (99 papers), Receptor Mechanisms and Signaling (82 papers) and Pain Mechanisms and Treatments (49 papers). Javier Garzón is often cited by papers focused on Neuropeptides and Animal Physiology (99 papers), Receptor Mechanisms and Signaling (82 papers) and Pain Mechanisms and Treatments (49 papers). Javier Garzón collaborates with scholars based in Spain, United States and United Kingdom. Javier Garzón's co-authors include Pilar Sánchez‐Blázquez, María Rodríguez-Muñoz, Almudena López‐Fando, Antonio García‐España, Ana Vicente‐Sánchez, Joaquı́n Del Rı́o, Esther Berrocoso, Manuel Merlos, Marián Castro and José Antonio del Rı́o and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Javier Garzón

147 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Garzón Spain 42 3.0k 2.7k 1.2k 588 232 147 4.4k
Pilar Sánchez‐Blázquez Spain 41 2.9k 1.0× 2.4k 0.9× 1.2k 1.0× 628 1.1× 260 1.1× 125 4.0k
Frédéric Simonin France 33 3.4k 1.1× 3.4k 1.2× 1.1k 1.0× 392 0.7× 233 1.0× 69 5.1k
Ivone Gomes United States 43 3.8k 1.3× 3.7k 1.4× 1.0k 0.9× 908 1.5× 361 1.6× 85 5.7k
Steven P. Wilson United States 40 2.1k 0.7× 2.1k 0.8× 1.5k 1.3× 472 0.8× 402 1.7× 121 4.7k
Dajan O’Donnell Canada 27 2.2k 0.7× 1.6k 0.6× 1.4k 1.2× 466 0.8× 269 1.2× 39 3.9k
Dominique Filliol France 30 2.4k 0.8× 2.1k 0.8× 844 0.7× 341 0.6× 218 0.9× 54 3.3k
Katia Befort France 30 4.5k 1.5× 3.5k 1.3× 2.2k 1.9× 576 1.0× 439 1.9× 56 6.4k
Ellen M. Unterwald United States 39 3.9k 1.3× 2.9k 1.1× 790 0.7× 396 0.7× 423 1.8× 127 5.1k
David B. Bylund United States 32 2.4k 0.8× 2.3k 0.9× 670 0.6× 245 0.4× 200 0.9× 89 4.1k
Daniel S. McGehee United States 36 3.1k 1.0× 3.9k 1.4× 675 0.6× 549 0.9× 572 2.5× 59 5.3k

Countries citing papers authored by Javier Garzón

Since Specialization
Citations

This map shows the geographic impact of Javier Garzón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Garzón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Garzón more than expected).

Fields of papers citing papers by Javier Garzón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Garzón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Garzón. The network helps show where Javier Garzón may publish in the future.

Co-authorship network of co-authors of Javier Garzón

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Garzón. A scholar is included among the top collaborators of Javier Garzón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Garzón. Javier Garzón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garzón, Javier, et al.. (2022). αN-Acetyl β-Endorphin Is an Endogenous Ligand of σ1Rs That Regulates Mu-Opioid Receptor Signaling by Exchanging G Proteins for σ2Rs in σ1R Oligomers. International Journal of Molecular Sciences. 24(1). 582–582. 4 indexed citations
2.
Rodríguez-Muñoz, María, et al.. (2021). Human HINT1 Mutant Proteins that Cause Axonal Motor Neuropathy Exhibit Anomalous Interactions with Partner Proteins. Molecular Neurobiology. 58(4). 1834–1845. 5 indexed citations
3.
Rodríguez-Muñoz, María, et al.. (2021). The σ1 Receptor and the HINT1 Protein Control α2δ1 Binding to Glutamate NMDA Receptors: Implications in Neuropathic Pain. Biomolecules. 11(11). 1681–1681. 11 indexed citations
4.
Rodríguez-Muñoz, María, et al.. (2020). The ALS-Related σ1R E102Q Mutant Eludes Ligand Control and Exhibits Anomalous Response to Calcium. International Journal of Molecular Sciences. 21(19). 7339–7339. 7 indexed citations
5.
Rodríguez-Muñoz, María, et al.. (2020). Calmodulin Supports TRPA1 Channel Association with Opioid Receptors and Glutamate NMDA Receptors in the Nervous Tissue. International Journal of Molecular Sciences. 22(1). 229–229. 11 indexed citations
6.
Hiraga, Shin‐ichiro, Tony Ly, Javier Garzón, et al.. (2017). Human RIF 1 and protein phosphatase 1 stimulate DNA replication origin licensing but suppress origin activation. EMBO Reports. 18(3). 403–419. 105 indexed citations
7.
Rodríguez-Muñoz, María, Pilar Sánchez‐Blázquez, Raquel Herrero-Labrador, et al.. (2015). The σ1 Receptor Engages the Redox-Regulated HINT1 Protein to Bring Opioid Analgesia Under NMDA Receptor Negative Control. Antioxidants and Redox Signaling. 22(10). 799–818. 68 indexed citations
8.
Rodríguez-Muñoz, María, et al.. (2011). NO-released Zinc Supports the Simultaneous Binding of Raf-1 and PKCγ Cysteine-Rich Domains to HINT1 Protein at the Mu-Opioid Receptor. Antioxidants and Redox Signaling. 14(12). 2413–2425. 31 indexed citations
9.
Rodríguez-Muñoz, María, Pilar Sánchez‐Blázquez, Ana Vicente‐Sánchez, Esther Berrocoso, & Javier Garzón. (2011). The Mu-Opioid Receptor and the NMDA Receptor Associate in PAG Neurons: Implications in Pain Control. Neuropsychopharmacology. 37(2). 338–349. 145 indexed citations
10.
Berrocoso, Esther, Pilar Sánchez‐Blázquez, Javier Garzón, & J.A. Micó. (2009). Opiates as Antidepressants. Current Pharmaceutical Design. 15(14). 1612–1622. 98 indexed citations
11.
Rodríguez-Muñoz, María, et al.. (2007). RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons. Cellular Signalling. 19(12). 2558–2571. 31 indexed citations
12.
Trompette, Aurélien, Jean Claustre, Javier Garzón, et al.. (2005). β-Casomorphin-7 regulates the secretion and expression of gastrointestinal mucins through a μ-opioid pathway. American Journal of Physiology-Gastrointestinal and Liver Physiology. 290(6). G1105–G1113. 112 indexed citations
13.
Garzón, Javier, et al.. (2005). Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS. Psychopharmacology. 180(1). 1–11. 29 indexed citations
14.
Garzón, Javier, María Rodríguez-Muñoz, Almudena López‐Fando, Antonio García‐España, & Pilar Sánchez‐Blázquez. (2004). RGSZ1 and GAIP Regulate μ- but Not δ-Opioid Receptors in Mouse CNS: Role in Tachyphylaxis and Acute Tolerance. Neuropsychopharmacology. 29(6). 1091–1104. 56 indexed citations
15.
Sánchez‐Blázquez, Pilar, M. Pilar Gómez‐Serranillos, & Javier Garzón. (2001). Agonists determine the pattern of G-protein activation in μ-opioid receptor-mediated supraspinal analgesia. Brain Research Bulletin. 54(2). 229–235. 78 indexed citations
16.
Garzón, Javier, et al.. (1999). Transport of CSF antibodies to Gα subunits across neural membranes requires binding to the target protein and protein kinase C activity. Molecular Brain Research. 65(2). 151–166. 9 indexed citations
17.
Garzón, Javier, et al.. (1997). GX/Z Is Regulated by μ But Not δ Opioid Receptors in the Stimulation of the Low Km GTPase Activity in Mouse Periaqueductal Grey Matter. European Journal of Neuroscience. 9(6). 1194–1200. 40 indexed citations
18.
Sánchez‐Blázquez, Pilar, Maite Rodriguez, & Javier Garzón. (1996). Antibodies directed against the mu-opioid receptor alleviated multiple signs of morphine withdrawal in mice. Life Sciences. 59(8). PL87–PL92. 6 indexed citations
19.
Sánchez‐Blázquez, Pilar, et al.. (1987). Incidence of morphine withdrawal and quasi-abstinence syndrome in a model of chronic pain in the rat. Neuroscience Letters. 81(1-2). 155–158. 11 indexed citations
20.
Fernández-Tomé, Paz, et al.. (1980). Increased dopamine receptor binding in the striatum of rats after long-term isolation. European Journal of Pharmacology. 65(4). 463–464. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pilar Sánchez‐Blázquez Breakdown of academic impact, for papers by Frédéric Simonin Breakdown of academic impact, for papers by Ivone Gomes Breakdown of academic impact, for papers by Steven P. Wilson Breakdown of academic impact, for papers by Dajan O’Donnell Breakdown of academic impact, for papers by Dominique Filliol Breakdown of academic impact, for papers by Katia Befort Breakdown of academic impact, for papers by Ellen M. Unterwald Breakdown of academic impact, for papers by David B. Bylund Breakdown of academic impact, for papers by Daniel S. McGehee
Rankless by CCL
2026